- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-452/14: Request for a preliminary ruling from the Consiglio di Stato (Italy) lodged on 29 September 2014 — Agenzia Italiana del Farmaco (AIFA), Ministry for Health v Doc Generici srl
ECLI:EU:UNKNOWN:62014CN0452
62014CN0452
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
15.12.2014
Official Journal of the European Union
C 448/8
(Case C-452/14)
(2014/C 448/11)
Language of the case: Italian
Referring court
Parties to the main proceedings
Applicants: Agenzia Italiana del Farmaco (AIFA), Ministry for Health
Defendant: Doc Generici srl
Questions referred
1.Must Article 3(2)(a) of Council Regulation (EC) No 297/95 of 10 February 1995, in the version currently in force, be interpreted as meaning that Type I marketing authorisation variations — and, in particular, in respect of the case in the main proceedings, Type IA variations — where an identical variation affecting several authorisations belonging to the same holder are concerned, are subject to a single fee, to the extent specified therein, or to as many fees as there are authorisations affected by the variation?
2.In the circumstances in the present proceedings, may or must, as held by this Chamber, the question be referred to the Court of Justice?
Council Regulation (EC) No 297/95 of 10 February 1995 on fees payable to the European Agency for the Evaluation of Medicinal Products (OJ 1995 L 35, 15.2.1995, p. 1).
* * *